Drugs · acquisition-cost intelligence
Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg
Aspirin and Dipyridamole· ingredient aspirinOther agents for local oral treatment· ASPIRIN 25 mg/1; DIPYRIDAMOLE 200 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.57275
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other aspirin products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| adult low dose aspirin | $0.01438 | −$0.55840 |
| Aspirin | $0.01601 | −$0.55670 |
| Aspirin | $0.02233 | −$0.55040 |
| Adult Chewable Aspirin | $0.02595 | −$0.54680 |
| AeroTab Pain Reliever | $0.04346 | −$0.52930 |
| ACETAMINOPHEN ASPIRIN AND CAFFEINE | $0.06716 | −$0.50560 |
| butalbital, aspirin, and caffeine | $0.97831 | +$0.40560 |
| Ascomp with Codeine | $1.09 | +$0.51460 |
Medicare Part D coverage · CY2026
On 319 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 23% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.